146 related articles for article (PubMed ID: 1312893)
1. Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses.
Emoto M; Iwasaki H; Kikuchi M; Ishiguro M; Kubota T; Izumi H; Shirakawa K; Kaneko Y
Cancer; 1992 Apr; 69(7):1759-68. PubMed ID: 1312893
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of cloned cells of mixed müllerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro.
Emoto M; Iwasaki H; Kikuchi M; Shirakawa K
Cancer; 1993 May; 71(10):3065-75. PubMed ID: 7683967
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of rhabdomyosarcoma cell lines derived from uterine carcinosarcomas.
Emoto M; Iwasaki H; Oshima K; Kikuchi M; Kaneko Y; Kawarabayashi T
Virchows Arch; 1997 Oct; 431(4):249-56. PubMed ID: 9368662
[TBL] [Abstract][Full Text] [Related]
4. Tissue polypeptide antigen production in a uterine carcinosarcoma cell line in a serum-free culture.
Emoto M; Iwasaki H; Kikuchi M; Shirakawa K
Gynecol Oncol; 1996 Mar; 60(3):443-9. PubMed ID: 8774655
[TBL] [Abstract][Full Text] [Related]
5. [Sarcomas of the uterus: immunohistochemical characterization and diagnosis].
Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):336-8. PubMed ID: 1284388
[TBL] [Abstract][Full Text] [Related]
6. Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.
Kairiyama C; Slavutsky I; Larripa I; Morvillo V; Bravo AI; Bover L; Podhajcer OL; Mordoh J
Pigment Cell Res; 1995 Jun; 8(3):121-31. PubMed ID: 7567787
[TBL] [Abstract][Full Text] [Related]
7. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of carcinosarcoma cell line of the human uterus.
Gorai I; Doi C; Minaguchi H
Cancer; 1993 Feb; 71(3):775-86. PubMed ID: 8431860
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a new human epithelioid sarcoma cell line, FU-EPS-1: molecular cytogenetic characterization by use of spectral karyotyping and comparative genomic hybridization.
Nishio J; Iwasaki H; Nabeshima K; Ishiguro M; Naumann S; Isayama T; Naito M; Kaneko Y; Kikuchi M; Bridge JA
Int J Oncol; 2005 Aug; 27(2):361-9. PubMed ID: 16010416
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of a case of malignant müllerian mixed tumor in comparison with the activity of normal uterine tissue.
Ohmori T
Histol Histopathol; 1989 Apr; 4(2):123-8. PubMed ID: 2562462
[TBL] [Abstract][Full Text] [Related]
11. Expression of various antigens by different components of uterine mixed müllerian tumors. An immunohistochemical study.
Chung MT; Mukai K; Teshima S; Kishi K; Shimosato Y
Acta Pathol Jpn; 1988 Jan; 38(1):35-45. PubMed ID: 2452553
[TBL] [Abstract][Full Text] [Related]
12. Two homologous mixed müllerian tumor lines of the ovary and their characteristics.
van Haaften-Day C; Russell P; Brammah-Carr S
Cancer; 1990 Apr; 65(8):1753-61. PubMed ID: 2156601
[TBL] [Abstract][Full Text] [Related]
13. Malignant mixed Müllerian tumors of the uterus. An immunohistochemical study.
Auerbach HE; LiVolsi VA; Merino MJ
Int J Gynecol Pathol; 1988; 7(2):123-30. PubMed ID: 3294195
[TBL] [Abstract][Full Text] [Related]
14. Concurrence of malignant and benign heterologous mixed tumors of the uterus.
Waxman M; Boyce JG; Macasaet MM; Lu T
Am J Clin Pathol; 1982 May; 77(5):631-7. PubMed ID: 6282114
[TBL] [Abstract][Full Text] [Related]
15. Establishment of three malignant peripheral nerve sheath tumor cell lines, FU-SFT8611, 8710 and 9817: conventional and molecular cytogenetic characterization.
Aoki M; Nabeshima K; Nishio J; Ishiguro M; Fujita C; Koga K; Hamasaki M; Kaneko Y; Iwasaki H
Int J Oncol; 2006 Dec; 29(6):1421-8. PubMed ID: 17088980
[TBL] [Abstract][Full Text] [Related]
16. Neuroectodermal immunophenotype in uterine malignant mullerian tumors (MMT): comparative immunohistochemical analysis with embryonal uterine development.
Karseladze A; Perevoshchikov A; Navarro S; Llombart-Bosch A
Eur J Gynaecol Oncol; 2004; 25(1):71-8. PubMed ID: 15053066
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
Meis JM; Lawrence WD
Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
[TBL] [Abstract][Full Text] [Related]
19. Complex karyotypic aberrations, including i(12p), in malignant mixed mullerian tumor of uterus.
Sreekantaiah C; Rao UN; Sandberg AA
Cancer Genet Cytogenet; 1992 May; 60(1):78-81. PubMed ID: 1317254
[TBL] [Abstract][Full Text] [Related]
20. [Malignant mixed Müllerian tumors of the uterus. Clinical, morphologic and immunohistochemical findings].
Falk S; Papaikonomou I; Böckler H; Stutte HJ
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):630-4. PubMed ID: 2550312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
